The factor V G1691A mutation is a risk for porencephaly: A case-control study

Otfried M Debus1, Andrea Kosch, Ronald Sträter

  • 1University Children's Hospital Münster, Department of Neuropediatrics, Germany. debuso@uni-muenster.de

Annals of Neurology
|August 5, 2004
PubMed

Insights

The factor V (FV) G1691A mutation and multiple prothrombotic factors are significantly linked to childhood porencephaly. These findings highlight key genetic and combined risk factors in the development of this neurological condition.

Area of Science:

  • Neurology
  • Pediatrics
  • Genetics

Background:

  • Porencephaly is a rare neurological disorder characterized by cystic lesions in the cerebral hemispheres.
  • The etiology of porencephaly is not fully understood, but genetic and environmental factors are suspected.
  • Prothrombotic risk factors have been implicated in various cerebrovascular diseases.

Purpose of the Study:

  • To investigate the association between specific prothrombotic risk factors and the occurrence of porencephaly in children.
  • To identify potential genetic predispositions contributing to the development of porencephaly.

Main Methods:

  • A case-control study comparing 76 children with porencephaly to 76 healthy infants.
  • Genetic analysis for factor V (FV) G1691A mutation, factor II G20210A variant, and methylenetetrahydrofolate reductase (MTHFR) C677T genotype.
  • Biochemical assays for lipoprotein (a), protein C, protein S, and antithrombin levels.

Main Results:

  • The factor V (FV) G1691A mutation was significantly associated with porencephaly (p = 0.005).
  • Combinations of two or three different prothrombotic risk factors showed a significant association with porencephaly (p = 0.003).
  • No significant association was found for factor II G20210A variant, MTHFR C677T genotype, lipoprotein (a), protein C, protein S, or antithrombin individually.

Conclusions:

  • The FV G1691A mutation is a significant risk factor in the development of childhood porencephaly.
  • The presence of multiple prothrombotic factors further increases the risk, suggesting a multifactorial etiology.
  • These findings underscore the role of thrombophilia in the pathogenesis of porencephaly and may inform future diagnostic and therapeutic strategies.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...